FGF Basic
No associated image currently available
Recombinant Human FGF basic represents the C-terminal protion of human fibroblast growth factor 2 (A135 - S288).
Fibroblast growth factor basic (FGF basic), also known as FGF 2, is a heparin binding growth factor which has stimulatory activity on a range of cells of mesenchymal, neuroectodermal and endothelial origin.
Note: FGF basic is sensitive to acidic conditions.
Fibroblast growth factor basic (FGF basic), also known as FGF 2, is a heparin binding growth factor which has stimulatory activity on a range of cells of mesenchymal, neuroectodermal and endothelial origin.
Note: FGF basic is sensitive to acidic conditions.
Product Details
- Target Species
- Human
- Product Form
- Purified recombinant protein expressed in E. coli - lyophilized
- Reconstitution
- Reconstitute with 0.5 ml Tris (5mM, pH7.6).
Care should be taken during reconstitution as the protein may appear as a film at the bottom of the vial. Bio-Rad recommend that the vial is gently mixed after reconstitution. Further dilutions may be prepared in a buffer containing a carrier protein (eg 0.1% BSA). - Buffer Solution
- TRIS buffered saline.
- Preservative Stabilisers
- None present
- Carrier Free
- Yes
- Activity
- 2 x 106 units/mg
- Purity
- >95% by SDS PAGE and HPLC analysis
- Approx. Protein Concentrations
- Total protein concentration 0.1 mg/ml after reconstitution.
- Protein Molecular Weight
- 17.2 kD (154 amino acid sequence)
- Endotoxin Level
- < 0.1 ng/ug
Storage Information
- Storage
- Prior to reconstitution store at -20oC. Following reconstitution store at -20oC.
This product should be stored undiluted.
Storage in frost-free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the protein. Should this product contain a precipitate we recommend microcentrifugation before use. - Guarantee
- Guaranteed for 3 months from the date of reconstitution or until the date of expiry, whichever comes first. Please see label for expiry date.
More Information
Applications of FGF Basic
| Application Name | Verified | Min Dilution | Max Dilution |
|---|---|---|---|
| ELISA | 0.2 | 0.4 ng/well | |
| Functional Assays | 0.1 | 10 ng/ml | |
| Western Blotting | 1.5 | 3.0 ng/lane |
Where this protein has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the protein for use in their own system using appropriate negative/positive controls.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Product Specific References
References for FGF Basic
-
Svendsen, C.N. et al. (1997) Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease.
Exp Neurol. 148: 135-46. -
Kim, T.H. et al. (2005) Recombinant human prothrombin kringle-2 induces bovine capillary endothelial cell cycle arrest at G0-G1 phase through inhibition of cyclin D1/CDK4 complex: modulation of reactive oxygen species generation and up-regulation of cyclin-dependent kinase inhibitors.
Angiogenesis. 8: 307-14. -
van Beuningen, HM et al. (2014) Inhibition of TAK1 and/or JAK can rescue impaired chondrogenic differentiation of human mesenchymal stem cells in osteoarthritis-like conditions.
Tissue Eng Part A. 20 (15-16): 2243-52. -
Pleumeekers, M.M. et al. (2014) The in vitro and in vivo capacity of culture-expanded human cells from several sources encapsulated in alginate to form cartilage.
Eur Cell Mater. 27: 264-80. -
Willems, N. et al. (2015) Intradiscal application of rhBMP-7 does not induce regeneration in a canine model of spontaneous intervertebral disc degeneration.
Arthritis Res Ther. 17: 137. -
Pleumeekers, M.M. et al. (2015) Cartilage regeneration in the head and neck area: Combination of ear or nasal chondrocytes and mesenchymal stem cells improves cartilage production: Cell combinations for cartilage production.
Plast Reconstr Surg. Aug 10. [Epub ahead of print] -
Dimitrellos, V. et al. (2003) Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor.
Biomed Chromatogr. 17 (1): 42-7. -
Narcisi R et al. (2015) Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulation.
Stem Cell Reports. 4 (3): 459-72. -
Lolli A et al. (2016) Silencing of anti-chondrogenic microRNA-221 in human mesenchymal stem cells promotes cartilage repair in vivo.
Stem Cells. Mar 1. [Epub ahead of print] -
de Kroon, L. M. G. et al. (2016) Activin and Nodal Are Not Suitable Alternatives to TGF for Chondrogenic Differentiation of Mesenchymal Stem Cells
Cartilage. Sep 7 [Epub ahead of print] -
Cleary, M.A. et al. (2016) Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential.
Osteoarthritis Cartilage. 24 (5): 868-72. -
Grotenhuis, N. et al. (2016) Biomaterials Influence Macrophage-Mesenchymal Stem Cell Interaction In Vitro.
Tissue Eng Part A. 22 (17-18): 1098-107. -
Rodrigues, A.I. et al. (2017) Calcium phosphates and silicon: exploring methods of incorporation.
Biomater Res. 21: 6. -
Le, B.Q. et al. (2015) High-Throughput Screening Assay for the Identification of Compounds Enhancing Collagenous Extracellular Matrix Production by ATDC5 Cells.
Tissue Eng Part C Methods. 21 (7): 726-36. -
Le, B.Q. et al. (2017) An Approach to In Vitro Manufacturing of Hypertrophic Cartilage Matrix for Bone Repair.
Bioengineering (Basel). 4 (2)Apr 20 [Epub ahead of print]. -
Bach, F.C. et al. (2017) Link-N: The missing link towards intervertebral disc repair is species-specific.
PLoS One. 12 (11): e0187831. -
Pleumeekers, M.M. et al. (2018) Trophic effects of adipose-tissue-derived and bone-marrow-derived mesenchymal stem cells enhance cartilage generation by chondrocytes in co-culture.
PLoS One. 13 (2): e0190744.
